BONDS/US670002AD60·USD·US·SENIOR UNSECUREDAS OF—

Novavax Inc

Novavax Inc 0.050% 2027/12 · bullet · 1.59y

United States

Tune RadioSIMILAR

YIELD TO MATURITY

—

semi-annual

MID PRICE

—

par = 100

BOND INFO

What this bond is

terms · risk · identifiers

Coupon

0.050%

semi-annual · fixed

Maturity

2027/12

1.59y · bullet

Mod. duration

—

n/a for perpetuals

Convexity

—

n/a for perpetuals

Outstanding

—

not disclosed

Issued

—

not disclosed

About this bond

AI BRIEF · GROUNDED IN STRUCTURED DATA

About the issuer

Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus (RSV), avian flu, shingles, Clostridioides difficile, and malaria.

Source: Wikipedia →

About this bond

AI BRIEF · LOADING

Identifiers

Security details

AWAITING ENRICHMENT

CUSIP

670002AD6

ISIN

US670002AD60

FACE

100 USD

SENIORITY

Senior Unsecured

BOND SIGNALS

What the market is saying

your fit · radio · footprint · upgrade for funds

For you

Your fit

Add positions to personalize — preview only

PREVIEW

Curve position

Rating cohort

Sector preference

Duration fit

Institutional footprint

Sherpa Signal

Minimal institutional footprint, holding

Breadth

5 / 25

Size

1 / 25

Concentration

6 / 15

Credit

DISCOVERY

Novavax Inc

What this bond is

About this bond

About this bond

Security details

What the market is saying

Your fit

Sherpa Signal

About this bond

Bonds like this